Kbi-092

is a standard technique used during coronary bifurcation stenting. American Heart Association Journals The Procedure

Many solid tumors exploit HPK1. Persistent antigen stimulation in the tumor microenvironment upregulates HPK1 activity, contributing to T cell dysfunction and exhaustion. By inhibiting HPK1, drugs like KBI-092 aim to lower the activation threshold of T cells, making them more resilient to suppressive signals and more effective at killing cancer cells. KBI-092

In semiconductor and microcontroller contexts (specifically NXP/Freescale MC9S08 series), refers to the Keyboard Interrupt is a standard technique used during coronary bifurcation